Greetings,
We are excited to share this early career opportunity from the National Institutes of Health (NIH). More information about the award can be found in the synopsis and links below.
NIH Stephen I. Katz Early Stage Investigator Research Project Grant (R01)
OSP Deadline: 5 business days prior to sponsor deadline. Departments or areas may require additional time for proposal review and submission. Please discuss a timeline with your grants administrator.
Sponsor Deadlines in 2024: January 26, May 29, and September 26
Award Amount: Application budgets are not limited but must reflect the proposed project's actual needs. The maximum project period is 5 years.
Eligibility: Early Stage Investigators. These are Principal Investigators (PIs) who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as PI for a substantial NIH independent research award.
The purpose of the Stephen I. Katz Early Stage Investigator Research Project Grant is to provide a new pathway for Early Stage Investigators (ESIs) who wish to propose research projects in a new direction for which preliminary data do not exist. These awards are open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers. Proposed projects must represent a change in research direction for the ESI and should be innovative and unique. A distinct feature of this award is that applications must not include preliminary data.
There are two NOFOs (Notices of Funding Opportunity) for this award:
This award is appropriate for ESIs who wish to initiate a research project in an area different from their previous research focus and/or training experience, and therefore have not produced preliminary data. Proposed research projects can rely on the PI’s prior work and expertise as its foundation, but must not be an incremental advancement, expansion, or extension of a previous research effort. The change in research direction could involve, for example, a new approach, methodology, technique, discipline, therapeutic target, and/or new paradigm, different from the ESI’s previous research efforts. Because a change in research direction is heavily dependent upon the area of investigation, potential applicants are strongly encouraged to contact a program director to discuss their proposed project. If the application proposes multiple Principal Investigators (MPIs), all PIs must be ESIs and the research direction must be a change in research direction for all MPIs.
Additional deadlines for this opportunity are January 28, May 28, and September 26, 2025, and January 27, May 27, and September 28, 2026.
Questions from FAS or SEAS faculty about this opportunity may be directed to research_development@fas.harvard.edu.